Ferra, Joana and Mousinho, Filipa and Miranda, Francisca and André, Sandra and Afonso, Celina and Nogueira, Fernando (2021) Use of Brentuximab Vedotin in a Non-HIV Patient with Primary Effusion Lymphoma. European Journal of Case Reports in Internal Medicine, 8 (2). pp. 1-3. ISSN ISSN: 2284-2594
|
Text
2345-Article Text-20766-1-10-20210218.pdf - Published Version Download (514kB) | Preview |
Abstract
Primary effusion lymphoma is a rare and aggressive large B-cell lymphoma presenting as malignant effusion with poor prognosis. Although it is more prevalent among HIV patients, it has also been described in non-HIV immunocompromised individuals. Given its rarity, there are no large randomized trials regarding the best therapeutic option. The choice of therapy is based on retrospective studies, case reports and preclinical data. We present the case of a non-HIV patient with relapsed disease after treatment with CHOP who was then successfully treated with brentuximab vedotin, achieving complete remission.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Primary effusion lymphoma, brentuximab vedotin, non-HIV |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 20 Dec 2021 15:12 |
| Last Modified: | 20 Dec 2021 15:12 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21176 |
Actions (login required)
 |
View Item |
